ClinVar Miner

Submissions for variant NM_000202.8(IDS):c.1454_1455del (p.Ile485fs)

dbSNP: rs2089305017
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001035366 SCV001198691 pathogenic Mucopolysaccharidosis, MPS-II 2019-12-04 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the IDS protein. Other variant(s) that disrupt this region (p.Arg468GlyfsX17, p.Gln531*, p.Tyr536*) have been observed in individuals with IDS-related conditions (PMID: 24550654, 17091340, 24125893). This suggests that this may be a clinically significant region of the protein. This variant has been observed in individual(s) with mucopolysaccharidosis II (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the IDS gene (p.Ile485Lysfs*13). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acids of the IDS protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.